Greenlane Renewables (GRN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 Mar, 2026Market opportunity and industry trends
Renewable natural gas (RNG) market is dynamic and fast-growing, with global demand projected to grow 15% annually through 2035 and even faster in Brazil at a 21% CAGR, driven by policy and industrial demand.
Biomethane is the fastest-growing form of bioenergy, essential for decarbonizing hard-to-abate sectors and enhancing energy security.
Brazil's biomethane demand is expected to increase sevenfold by 2035, supported by new regulations and vast agricultural resources.
Business model and product innovation
Operates across three business areas: proprietary standard products, system integration and delivery, and parts and service.
Proprietary product lines include Cascade LF (landfill gas upgrading), Cascade H2S (biogas desulfurization), Cascade MS (membrane separation), and Cascade H2O (water wash).
Focus on solving industry challenges such as cost-effective H2S removal and high-performance landfill gas upgrading.
Pipeline of advanced products targets high-demand, fast-growing markets, with new IP filings supporting innovation.
Financial performance and discipline
Achieved 28% adjusted EBITDA in 2025 from parts, service, and proprietary products, with $44.4M revenue and $2.3M adjusted EBITDA.
Maintains a solid cash balance ($17.7M at year-end 2025) and operates with no debt.
Demonstrated strong positive adjusted EBITDA growth, especially in proprietary products and services, while ramping down low-margin integration contracts.
Latest events from Greenlane Renewables
- Positive Adjusted EBITDA, strong cash, and record backlog signal improved profitability and growth.GRN
Q4 202513 Mar 2026 - Strong growth in RNG, innovation, and financial discipline drive expansion and improved profitability.GRN
Investor presentation12 Mar 2026 - Revenue, margins, and service contracts improved, but project delays and backlog remain challenges.GRN
Q2 20242 Feb 2026 - Revenue up 10%, cash up 70%, losses narrowed, but positive EBITDA for 2024 not expected.GRN
Q3 202415 Jan 2026 - Adjusted EBITDA loss narrowed 81% and gross margin rose to 32% for FY2024.GRN
Q4 202426 Dec 2025 - Q1 2025 saw strong margins, stable cash, and a robust sales backlog amid global growth opportunities.GRN
Q1 202525 Nov 2025 - Profitability, strong revenue growth, and Cascade LF launch highlight positive momentum.GRN
Q3 202517 Nov 2025 - Q2 2025 delivered higher revenue, strong margins, and a growing sales backlog, supporting strategic growth.GRN
Q2 202514 Aug 2025